Changes

Jump to navigation Jump to search
183 bytes added ,  15:52, 6 November 2010
Line 16: Line 16:  
'''Exogenous vaccines''' are when the antigen is processed from the outside by endocytosis without any new proteins being made by the host cell. This involves [[Major Histocompatability Complexes#MHC II|MHC class II]] processing inactivated and subunit vaccines.
 
'''Exogenous vaccines''' are when the antigen is processed from the outside by endocytosis without any new proteins being made by the host cell. This involves [[Major Histocompatability Complexes#MHC II|MHC class II]] processing inactivated and subunit vaccines.
   −
==How do we vaccinate?==
+
==Route of Administration==
 
+
*Usually by subcutaneous injection for '''systemic''' protection ([[Immunoglobulin G|IgG]]). Some vaccines such as the [[Myxomatosis|myxomatosis]] vaccine NobivacTM Myxo (Intervet UK Ltd) require an intradermal injection as part of the administration procedure.
*Usually by subcutaneous injection for '''systemic''' protection ([[Immunoglobulin G|IgG]])
+
*For a localised '''mucosal''' immune response, intranasal administration is best ([[Immunoglobulin A|IgA]])
 
  −
*For '''mucosal''' immune response, intranasal administration is best ([[Immunoglobulin A|IgA]])
      
==What do we vaccinate with?==
 
==What do we vaccinate with?==
5,582

edits

Navigation menu